deltatrials
Completed PHASE1 NCT00002104

Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV

Sponsor: Aaron Diamond AIDS Research Center

Conditions HIV Infections Mycobacterium Avium-Intracellulare Infection Tuberculosis, Mycobacterium Infection
Interventions Thalidomide
Updated 5 times since 2017 Last updated: Jun 23, 2005

A PHASE1 clinical study on HIV Infections and Mycobacterium Avium-Intracellulare Infection, this trial is completed. The trial is conducted by Aaron Diamond AIDS Research Center and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Aaron Diamond AIDS Research Center
Data source: NIH AIDS Clinical Trials Information Service

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States